Literature DB >> 25155037

Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1.

Guoying Lao1, Ping Liu, Qiongwei Wu, Wenying Zhang, Yu Liu, Longtao Yang, Chengbin Ma.   

Abstract

MicroRNAs (miRNAs) are important regulators of many physiological and pathological processes, including cell proliferation, apoptosis, and cell cycle arrest. In this study, we aimed to investigate the biological role of miR-155 in cervical cancer and the underlying molecular mechanism involved in tumorigenesis. The expression of miR-155 in human cervical cancer tissues was detected by real-time PCR. MTT assay and BrdU incorporation assay were used to measure the proliferation of cervical cancer cells. Apoptosis cells and cell cycle distribution were analyzed by flow cytometry. We found that the expression of miR-155 was upregulated in cervical cancer tissues compared to the adjacent non-cancer tissues. Overexpression of miR-155 promoted the proliferation of Hela and SiHa cells. By contrast, downregulation of miR-155 inhibited the growth of cervical cancer cells. Flow cytometry analysis showed that low expression of miR-155 promoted apoptosis and induced cell cycle arrest in Hela and SiHa cells. Moreover, the mRNA and protein expression of LKB1 was significantly reduced in cervical cancer tissues. Luciferase reporter assay demonstrated that LKB1 was a target gene of miR-155, suggesting that miRNA-155 promoted the proliferation of cervical cancer cells by regulating LKB1 expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25155037     DOI: 10.1007/s13277-014-2479-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  27 in total

1.  LKB1 modulates lung cancer differentiation and metastasis.

Authors:  Hongbin Ji; Matthew R Ramsey; D Neil Hayes; Cheng Fan; Kate McNamara; Piotr Kozlowski; Chad Torrice; Michael C Wu; Takeshi Shimamura; Samanthi A Perera; Mei-Chih Liang; Dongpo Cai; George N Naumov; Lei Bao; Cristina M Contreras; Danan Li; Liang Chen; Janakiraman Krishnamurthy; Jussi Koivunen; Lucian R Chirieac; Robert F Padera; Roderick T Bronson; Neal I Lindeman; David C Christiani; Xihong Lin; Geoffrey I Shapiro; Pasi A Jänne; Bruce E Johnson; Matthew Meyerson; David J Kwiatkowski; Diego H Castrillon; Nabeel Bardeesy; Norman E Sharpless; Kwok-Kin Wong
Journal:  Nature       Date:  2007-08-05       Impact factor: 49.962

2.  MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.

Authors:  Shuai Jiang; Hong-Wei Zhang; Ming-Hua Lu; Xiao-Hong He; Yong Li; Hua Gu; Mo-Fang Liu; En-Duo Wang
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

3.  Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  N Colombo; S Carinelli; A Colombo; C Marini; D Rollo; C Sessa
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

4.  The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines.

Authors:  Wolfgang Glienke; Luise Maute; Johannes Wicht; Lothar Bergmann
Journal:  Tumour Biol       Date:  2011-12-15

Review 5.  High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer.

Authors:  Miaomiao Yang; Hongchang Shen; Chen Qiu; Yang Ni; Liguang Wang; Wei Dong; Yida Liao; Jiajun Du
Journal:  Eur J Cancer       Date:  2012-10-22       Impact factor: 9.162

6.  The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.

Authors:  David B Shackelford; Reuben J Shaw
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

7.  Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.

Authors:  Meritxell Gironella; Mylène Seux; Min-Jue Xie; Carla Cano; Richard Tomasini; Julien Gommeaux; Stephane Garcia; Jonathan Nowak; Man Lung Yeung; Kuan-Teh Jeang; Amandine Chaix; Ladan Fazli; Yoshiharu Motoo; Qing Wang; Palma Rocchi; Antonio Russo; Martin Gleave; Jean-Charles Dagorn; Juan L Iovanna; Alice Carrier; Marie-Josèphe Pébusque; Nelson J Dusetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

8.  A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity.

Authors:  Sophie G Martin; Daniel St Johnston
Journal:  Nature       Date:  2003-01-23       Impact factor: 49.962

9.  Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice.

Authors:  Stefan Costinean; Sukhinder K Sandhu; Irene M Pedersen; Esmerina Tili; Rossana Trotta; Danilo Perrotti; David Ciarlariello; Paolo Neviani; Jason Harb; Lauren Rachel Kauffman; Aaditya Shidham; Carlo Maria Croce
Journal:  Blood       Date:  2009-06-11       Impact factor: 22.113

10.  Epigenetic regulation of microRNA expression in colorectal cancer.

Authors:  Eva Bandres; Xabier Agirre; Nerea Bitarte; Natalia Ramirez; Ruth Zarate; Jose Roman-Gomez; Felipe Prosper; Jesus Garcia-Foncillas
Journal:  Int J Cancer       Date:  2009-12-01       Impact factor: 7.396

View more
  30 in total

1.  MicroRNA-30a suppresses non-small-cell lung cancer by targeting Myb-related protein B.

Authors:  Guo-Jun Geng; Ying-Tao Yang; Jie Jiang; Xiu-Yi Yu; Xian-En Fa
Journal:  Exp Ther Med       Date:  2017-11-24       Impact factor: 2.447

2.  Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.

Authors:  Cornelia Lerner; Silke Wemmert; Florian Bochen; Philipp Kulas; Maximilian Linxweiler; Andrea Hasenfus; Joana Heinzelmann; Petra Leidinger; Christina Backes; Eckart Meese; Steffi Urbschat; Bernhard Schick
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-30       Impact factor: 4.553

Review 3.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

4.  Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study.

Authors:  Eric J Duell; Leila Lujan-Barroso; Núria Sala; Samantha Deitz McElyea; Kim Overvad; Anne Tjonneland; Anja Olsen; Elisabete Weiderpass; Lill-Tove Busund; Line Moi; David Muller; Paolo Vineis; Dagfinn Aune; Giuseppe Matullo; Alessio Naccarati; Salvatore Panico; Giovanna Tagliabue; Rosario Tumino; Domenico Palli; Rudolf Kaaks; Verena A Katzke; Heiner Boeing; H B As Bueno-de-Mesquita; Petra H Peeters; Antonia Trichopoulou; Pagona Lagiou; Anastasia Kotanidou; Ruth C Travis; Nick Wareham; Kay-Tee Khaw; Jose Ramon Quiros; Miguel Rodríguez-Barranco; Miren Dorronsoro; María-Dolores Chirlaque; Eva Ardanaz; Gianluca Severi; Marie-Christine Boutron-Ruault; Vinciane Rebours; Paul Brennan; Marc Gunter; Ghislaine Scelo; Greg Cote; Stuart Sherman; Murray Korc
Journal:  Int J Cancer       Date:  2017-06-12       Impact factor: 7.396

5.  Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.

Authors:  Yue Xu; Shuhua Zhao; Manhua Cui; Qiang Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 6.  Small molecules targeting microRNA for cancer therapy: Promises and obstacles.

Authors:  Di Wen; Michael Danquah; Amit Kumar Chaudhary; Ram I Mahato
Journal:  J Control Release       Date:  2015-08-06       Impact factor: 9.776

7.  Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2.

Authors:  Yuan-Xue Jiang; Zi-Ming Du; Lin Jiao; Qiong Shao; Sha Fu; Jian-Yong Shao; Xiao-Feng Zhu; Ingemar Ernberg; Yu-Hong Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

8.  Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells.

Authors:  Fangfang Guo; Xueqi Fu; Jili Yang; Xueying Zhang; Dezhi Liu; Wenjuan Feng; Jinyu Liu; Jinhong Qi; Huifang Cao; Li Qi; Jingyuan Ren
Journal:  Int J Clin Exp Pathol       Date:  2017-09-01

9.  MiR-155 modulates the progression of neuropathic pain through targeting SGK3.

Authors:  Shaoxing Liu; Bo Zhu; Yan Sun; Xianfeng Xie
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  Liver kinase B1 promoter CpG island methylation is related to lung cancer and smoking.

Authors:  Rongju Sun; Jie Li; Bo Wang; Yingfei Guo; Lingyun Ma; Xiaojiao Quan; Zhixiang Chu; Tanshi Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.